BMBF once again announces funding program for clinical studies
06.05.2013 18:23
The “Clinical Studies” funding program, jointly supported by the Federal Ministry of Education and Research (BMBF) and the German Research Foundation (DFG), is being advertised again. An interim evaluation of the last funding program showed that there are still deficiencies in the planning and implementation of science-initiated clinical studies and that greater emphasis must be placed on the relevance to everyday medical practice in funding. When selecting funding applications, the importance of the question for the affected patients and for everyday medical practice in Germany will be particularly assessed.
Science-initiated multicenter prospective, controlled clinical studies with patients to demonstrate the effectiveness of novel therapeutic, diagnostic or prognostic procedures with confirmatory objectives should be funded. Monocentric confirmatory studies can only be funded in justified exceptional cases. But also systematic reviews of clinical studies according to international standards. Gender and age group-specific aspects should be taken into account appropriately in the studies.
Research approaches that are already included in other funding programs such as: B. the normal procedure of the DFG or other funding priorities of the BMBF can be applied for or supported, as well as studies whose results commercial companies have a direct economic interest (such as approval studies).
It is planned that study applications can be submitted at annual intervals. If necessary, different clinical topics will be determined for each appointment. The exact annual submission deadlines and the specified focus areas will be announced separately and at http://www.gesundheitsforschung-bmbf.de/de/aktuelle-bekanntmachungen.php as well as in Application Guide published. The application outlines can now be submitted to the project sponsor at DLR, which the BMBF has commissioned to handle the funding measure by June 27, 2013 at the latest be submitted electronically via the portal mentioned above.